Qube Research & Technologies LTD Nektar Therapeutics Transaction History

Qube Research & Technologies LTD

  • $72.9 Billion
  • Q4 2024

A detailed history of Qube Research & Technologies LTD transactions in Nektar Therapeutics stock. As of the latest transaction made, Qube Research & Technologies LTD holds 65,759 shares of NKTR stock, worth $69,704. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,759
Holding current value
$69,704
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$0.9 - $1.45 $59,183 - $95,350
65,759 New
65,759 $61,000
Q2 2024

Aug 14, 2024
SELL
$0.9 - $1.83 $24,795 - $50,418
-27,551 Reduced 62.82%
16,304 $20,000
Q1 2024

May 14, 2024
BUY
$0.49 - $0.96 $8,777 - $17,196
17,913 Added 69.05%
43,855 $40,000
Q4 2023

Feb 13, 2024
SELL
$0.42 - $0.57 $13,266 - $18,004
-31,586 Reduced 54.91%
25,942 $14,000
Q3 2023

Nov 13, 2023
SELL
$0.51 - $1.05 $163,643 - $336,913
-320,870 Reduced 84.8%
57,528 $34,000
Q2 2023

Aug 14, 2023
BUY
$0.53 - $1.03 $200,550 - $389,749
378,398 New
378,398 $219,000
Q4 2022

Feb 14, 2023
BUY
$2.03 - $4.28 $110,472 - $232,917
54,420 New
54,420 $122,000
Q2 2022

Aug 15, 2022
BUY
$3.17 - $6.17 $140,973 - $274,386
44,471 New
44,471 $169,000
Q1 2020

May 15, 2020
SELL
$14.47 - $27.96 $407,431 - $787,269
-28,157 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$15.87 - $23.12 $446,851 - $650,989
28,157 New
28,157 $608,000
Q3 2019

Nov 13, 2019
SELL
$16.91 - $36.27 $155,656 - $333,865
-9,205 Closed
0 $0
Q2 2019

Aug 02, 2019
BUY
$31.0 - $36.3 $285,355 - $334,141
9,205 New
9,205 $328,000
Q1 2019

May 15, 2019
SELL
$31.58 - $46.35 $196,964 - $289,084
-6,237 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$30.43 - $56.65 $14,880 - $27,701
-489 Reduced 7.27%
6,237 $205,000
Q3 2018

Nov 14, 2018
BUY
$46.46 - $68.49 $312,489 - $460,663
6,726 New
6,726 $410,000

Others Institutions Holding NKTR

# of Institutions
152
Shares Held
131M
Call Options Held
92.7K
Put Options Held
4.9K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $199M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email